{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T20:57:00Z","timestamp":1786913820887,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009017","name":"ALS Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009408","name":"Fondation Brain Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003607","name":"Association for Frontotemporal Degeneration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.neurot.2026.e00834","type":"journal-article","created":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:03:35Z","timestamp":1768712615000},"page":"e00834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Small molecule JRMS modulating importin-\u03b21 chaperone activity as a therapeutic strategy reducing TDP-43 pathology"],"prefix":"10.1016","volume":"23","author":[{"given":"Marc","family":"Shenouda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Shenouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Kartono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shehab","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neurot.2026.e00834_bib1","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","article-title":"TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"351","author":"Arai","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"5796","key":"10.1016\/j.neurot.2026.e00834_bib2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00834_bib3","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00834_bib4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13024-021-00503-x","article-title":"TDP-43 pathology in Alzheimer's Disease","volume":"16","author":"Meneses","year":"2021","journal-title":"Mol Neurodegener"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00834_bib5","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1128\/jvi.69.6.3584-3596.1995","article-title":"Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs","volume":"69","author":"Ou","year":"1995","journal-title":"J Virol"},{"issue":"39","key":"10.1016\/j.neurot.2026.e00834_bib6","doi-asserted-by":"crossref","first-page":"36337","DOI":"10.1074\/jbc.M104236200","article-title":"Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9","volume":"276","author":"Buratti","year":"2001","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00834_bib7","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/nn.3230","article-title":"Divergent roles of ALS-linked proteins FUS\/TLS and TDP-43 intersect in processing long pre-mRNAs","volume":"15","author":"Lagier-Tourenne","year":"2012","journal-title":"Nat Neurosci"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00834_bib8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nn.2779","article-title":"Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43","volume":"14","author":"Polymenidou","year":"2011","journal-title":"Nat Neurosci"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00834_bib9","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nn.2778","article-title":"Characterizing the RNA targets and position-dependent splicing regulation by TDP-43","volume":"14","author":"Tollervey","year":"2011","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurot.2026.e00834_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnmol.2019.00025","article-title":"Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis","volume":"12","author":"Prasad","year":"2019","journal-title":"Front Mol Neurosci"},{"issue":"Pt 22","key":"10.1016\/j.neurot.2026.e00834_bib11","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1242\/jcs.038950","article-title":"Structural determinants of the cellular localization and shuttling of TDP-43","volume":"121","author":"Ayala","year":"2008","journal-title":"J Cell Sci"},{"key":"10.1016\/j.neurot.2026.e00834_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fnmol.2019.00301","article-title":"Structural insights into TDP-43 and effects of post-translational modifications","volume":"12","author":"Francois-Moutal","year":"2019","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00834_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ana.21425","article-title":"Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"64","author":"Hasegawa","year":"2008","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00834_bib14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00401-008-0402-2","article-title":"White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62, but not ubiquitin","volume":"116","author":"Hiji","year":"2008","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00834_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115113","article-title":"TDP43 autoregulation gives rise to dominant negative isoforms that are tightly controlled by transcriptional and post-translational mechanisms","volume":"44","author":"Dykstra","year":"2025","journal-title":"Cell Rep"},{"key":"10.1016\/j.neurot.2026.e00834_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.868556","article-title":"A C-Terminally truncated TDP-43 splice isoform exhibits neuronal specific cytoplasmic aggregation and contributes to TDP-43 pathology in ALS","volume":"16","author":"Shenouda","year":"2022","journal-title":"Front Neurosci"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00834_bib17","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1172\/JCI130988","article-title":"Shortened TDP43 isoforms upregulated by neuronal hyperactivity drive TDP43 pathology in ALS","volume":"130","author":"Weskamp","year":"2020","journal-title":"J Clin Investig"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00834_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00401-015-1412-5","article-title":"Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death","volume":"130","author":"Xiao","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"18","key":"10.1016\/j.neurot.2026.e00834_bib19","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.1073\/pnas.0900688106","article-title":"Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00834_bib20","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.celrep.2019.04.003","article-title":"Loss of nuclear TDP-43 is associated with decondensation of LINE retrotransposons","volume":"27","author":"Liu","year":"2019","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00834_bib21","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/nan.12148","article-title":"Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones","volume":"40","author":"Highley","year":"2014","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6248","key":"10.1016\/j.neurot.2026.e00834_bib22","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1126\/science.aab0983","article-title":"TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD","volume":"349","author":"Ling","year":"2015","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00834_bib23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s13311-015-0338-x","article-title":"TDP-43 proteinopathy and ALS: insights into disease mechanisms and therapeutic targets","volume":"12","author":"Scotter","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"22","key":"10.1016\/j.neurot.2026.e00834_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212380","article-title":"Co-Aggregation of TDP-43 with other pathogenic proteins and their Co-Pathologies in neurodegenerative diseases","volume":"25","author":"Jiang","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"15","key":"10.1016\/j.neurot.2026.e00834_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153685","article-title":"Partial failure of proteostasis systems counteracting TDP-43 aggregates in neurodegenerative diseases","volume":"20","author":"Cascella","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"23","key":"10.1016\/j.neurot.2026.e00834_bib26","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1093\/hmg\/ddt319","article-title":"The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons","volume":"22","author":"Wang","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00834_bib27","doi-asserted-by":"crossref","first-page":"800","DOI":"10.4103\/1673-5374.382233","article-title":"The pathogenic mechanism of TAR DNA-binding protein 43 (TDP-43) in amyotrophic lateral sclerosis","volume":"19","author":"Wang","year":"2024","journal-title":"Neural Regen Res"},{"issue":"8","key":"10.1016\/j.neurot.2026.e00834_bib28","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nm.4130","article-title":"The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity","volume":"22","author":"Wang","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.neurot.2026.e00834_bib29","series-title":"TDP-43 aggregate seeding impairs autoregulation and causes TDP-43 dysfunction","author":"Mamede","year":"2025"},{"issue":"10","key":"10.1016\/j.neurot.2026.e00834_bib30","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.neuron.2025.03.004","article-title":"TDP-43 seeding induces cytoplasmic aggregation heterogeneity and nuclear loss of function of TDP-43","volume":"113","author":"Rummens","year":"2025","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.neurot.2026.e00834_bib31","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.neuron.2025.03.008","article-title":"Seeded aggregation of TDP-43 induces its loss of function and reveals early pathological signatures","volume":"113","author":"Scialo","year":"2025","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00834_bib32","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41593-017-0047-3","article-title":"TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS\/FTD","volume":"21","author":"Chou","year":"2018","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00834_bib33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.neuron.2019.02.038","article-title":"Cytoplasmic TDP-43 De-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death","volume":"102","author":"Gasset-Rosa","year":"2019","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00834_bib34","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.cell.2018.03.002","article-title":"Nuclear-import receptors reverse aberrant phase transitions of RNA-binding proteins with prion-like domains","volume":"173","author":"Guo","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00834_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167220","article-title":"Nuclear-import receptors counter deleterious phase transitions in neurodegenerative disease","volume":"434","author":"Odeh","year":"2022","journal-title":"J Mol Biol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00834_bib36","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13024-022-00585-1","article-title":"Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathy","volume":"17","author":"Khalil","year":"2022","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00834_bib37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13024-023-00698-1","article-title":"Nuclear-import receptors as gatekeepers of pathological phase transitions in ALS\/FTD","volume":"19","author":"Khalil","year":"2024","journal-title":"Mol Neurodegener"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00834_bib38","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/emboj\/21.3.377","article-title":"Importins fulfil a dual function as nuclear import receptors and cytoplasmic chaperones for exposed basic domains","volume":"21","author":"J\u00e4kel","year":"2002","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00834_bib39","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1038\/s41598-021-83196-y","article-title":"Mechanism of karyopherin-beta2 binding and nuclear import of ALS variants FUS(P525L) and FUS(R495X)","volume":"11","author":"Gonzalez","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2026.e00834_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100659","article-title":"The RNA-binding protein FUS is chaperoned and imported into the nucleus by a network of import receptors","volume":"296","author":"Baade","year":"2021","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.neurot.2026.e00834_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108538","article-title":"Nuclear import receptors directly bind to arginine-rich dipeptide repeat proteins and suppress their pathological interactions","volume":"33","author":"Hutten","year":"2020","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00834_bib42","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1158\/1535-7163.MCT-15-0052","article-title":"Targeting the nuclear import receptor Kpn\u03b21 as an anticancer therapeutic","volume":"15","author":"van der Watt","year":"2016","journal-title":"Mol Cancer Therapeut"},{"key":"10.1016\/j.neurot.2026.e00834_bib43","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/978-3-319-89689-2_9","article-title":"Mechanisms associated with TDP-43 neurotoxicity in ALS\/FTLD","volume":"20","author":"Shenouda","year":"2018","journal-title":"Adv Neurobiol"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00834_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143238","article-title":"Functional characterization of IPSC-derived brain cells as a model for X-Linked adrenoleukodystrophy","volume":"10","author":"Baarine","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00834_bib45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s40478-025-02061-5","article-title":"C9orf72 deficiency impairs the autophagic response to aggregated TDP-25 and exacerbates TDP-25-mediated neurodegeneration in vivo","volume":"13","author":"Lin","year":"2025","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00834_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112134","article-title":"Loss of C9orf72 perturbs the Ran-GTPase gradient and nucleocytoplasmic transport, generating compositionally diverse importin \u03b2-1 granules","volume":"42","author":"McGoldrick","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.neurot.2026.e00834_bib47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neulet.2014.05.044","article-title":"Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection","volume":"576","author":"McLean","year":"2014","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00834_bib48","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/ana.24469","article-title":"Isoform-specific antibodies reveal distinct subcellular localizations of C9orf72 in amyotrophic lateral sclerosis","volume":"78","author":"Xiao","year":"2015","journal-title":"Ann Neurol"},{"issue":"7567","key":"10.1016\/j.neurot.2026.e00834_bib49","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature14973","article-title":"The C9orf72 repeat expansion disrupts nucleocytoplasmic transport","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00834_bib50","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nprot.2008.13","article-title":"The prion organotypic slice culture assay--POSCA","volume":"3","author":"Falsig","year":"2008","journal-title":"Nat Protoc"},{"issue":"19","key":"10.1016\/j.neurot.2026.e00834_bib51","doi-asserted-by":"crossref","first-page":"13302","DOI":"10.1074\/jbc.M800342200","article-title":"Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation","volume":"283","author":"Winton","year":"2008","journal-title":"J Biol Chem"},{"issue":"14","key":"10.1016\/j.neurot.2026.e00834_bib52","doi-asserted-by":"crossref","first-page":"R502","DOI":"10.1016\/S0960-9822(02)00970-3","article-title":"The Ran GTPase: theme and variations","volume":"12","author":"Dasso","year":"2002","journal-title":"Curr Biol"},{"issue":"8","key":"10.1016\/j.neurot.2026.e00834_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084165","article-title":"Nucleocytoplasmic transport: regulatory mechanisms and the implications in neurodegeneration","volume":"22","author":"Ding","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00834_bib54","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/jnnp-2020-322983","article-title":"TDP-43 proteinopathies: a new wave of neurodegenerative diseases","volume":"92","author":"de Boer","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00834_bib55","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a024554","article-title":"Biology and pathobiology of TDP-43 and emergent therapeutic strategies","volume":"7","author":"Guo","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00834_bib56","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s13311-022-01260-5","article-title":"Emerging therapies and novel targets for TDP-43 proteinopathy in ALS\/FTD","volume":"19","author":"Hayes","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00834_bib57","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.molcel.2018.07.002","article-title":"Poly(ADP-Ribose) prevents pathological phase separation of TDP-43 by promoting liquid demixing and stress granule localization","volume":"71","author":"McGurk","year":"2018","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00834_bib58","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cell.2015.09.015","article-title":"Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization","volume":"163","author":"Molliex","year":"2015","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00834_bib59","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neuron.2019.03.041","article-title":"The evolution of phase-separated TDP-43 in stress","volume":"102","author":"Wolozin","year":"2019","journal-title":"Neuron"},{"issue":"15","key":"10.1016\/j.neurot.2026.e00834_bib60","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.febslet.2015.06.009","article-title":"TDP-35 sequesters TDP-43 into cytoplasmic inclusions through binding with RNA","volume":"589","author":"Che","year":"2015","journal-title":"FEBS Lett"},{"issue":"Pt 6","key":"10.1016\/j.neurot.2026.e00834_bib61","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/brain\/awq111","article-title":"Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration","volume":"133","author":"Nishimura","year":"2010","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00834_bib62","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.tibs.2015.11.001","article-title":"Transport selectivity of nuclear pores, phase separation, and membraneless organelles","volume":"41","author":"Schmidt","year":"2016","journal-title":"Trends Biochem Sci"},{"issue":"13","key":"10.1016\/j.neurot.2026.e00834_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111007","article-title":"Recognition of the TDP-43 nuclear localization signal by importin alpha1\/beta","volume":"39","author":"Doll","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.neurot.2026.e00834_bib64","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1146\/annurev.cellbio.15.1.607","article-title":"Transport between the cell nucleus and the cytoplasm","volume":"15","author":"G\u00f6rlich","year":"1999","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"20","key":"10.1016\/j.neurot.2026.e00834_bib65","doi-asserted-by":"crossref","first-page":"32833","DOI":"10.18632\/oncotarget.15834","article-title":"KPNB1-mediated nuclear import is required for motility and inflammatory transcription factor activity in cervical cancer cells","volume":"8","author":"Stelma","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00834_bib66","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.tcb.2018.12.004","article-title":"Therapeutic dissolution of aberrant phases by nuclear-import receptors","volume":"29","author":"Guo","year":"2019","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.neurot.2026.e00834_bib67","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ceb.2020.04.003","article-title":"Karyopherins and condensates","volume":"64","author":"Springhower","year":"2020","journal-title":"Curr Opin Cell Biol"},{"issue":"6733","key":"10.1016\/j.neurot.2026.e00834_bib68","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/20367","article-title":"Structure of importin-\u03b2 bound to the IBB domain of importin-\u03b1","volume":"399","author":"Cingolani","year":"1999","journal-title":"Nature"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926000048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926000048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T05:25:34Z","timestamp":1773984334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926000048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1878747926000048"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00834","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small molecule JRMS modulating importin-\u03b21 chaperone activity as a therapeutic strategy reducing TDP-43 pathology","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00834","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00834"}}